Through the partnership, Children’s National will leverage KenSci’s AI platform to test predictive patient models it previously developed to study transitions to and from intensive care units. Models from George Washington University will also be tested.
“Since the mid-80s we have been able to predict mortality risks in pediatric ICUs using risk scores. In most cases these scores are used for quality assessment,” said Murray Pollack, MD, outcomes research director at Children’s National, according to a news release emailed to Becker’s Hospital Review. “Our collaborative goals are to study the temporal variation in data, taking the first step towards dynamic risk scoring for pediatric ICUs.”
More articles on artificial intelligence:
Microsoft invests $1B for development of superhuman AI
10 most common AI uses in healthcare
Philips leads $6.8M funding round for AI-driven health tech startup
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
